Amylyx began the Phase 1 LUMINA clinical trial of AMX0114, an investigational antisense oligonucleotide (ASO) targeting calpain-2, for people living with amyotrophic lateral sclerosis (ALS).

Seven students from among more than 300 entrants from the Loudoun County Public Schools Regional Science and Engineering Fair ...

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2024 Earnings Call Transcript March 4, 2025 Amylyx Pharmaceuticals, Inc. misses ...

AMX0014, meanwhile, is a calpain-2-targeting antisense drug, in late preclinical development, with an initial clinical trial due to start before year-end. “Our pipeline is supported by ...

Type 2 diabetes can be inherited, but environmental factors also play a role. Not everyone with a family history of type 2 diabetes will get it, but you’re more likely to develop it if a parent ...

After just over a month of release, the Chinese mega-hit Ne Zha 2 has passed the $2 billion mark at the global box office. More precisely, it took just 33 days to achieve this unprecedented feat.

Nintendo Switch 2 is finally confirmed. After literal years of unverified rumors, dubious leaks and copious amounts of online speculation, Nintendo has lifted the lid on its next-generation ...

While there’s no cure for early onset Alzheimer’s disease, medications and supportive therapies can help manage symptoms related to memory loss, cognitive decline, and functional impairment ...